Postoperative Cost-effectiveness of Prophylactic Amino Acid Therapy for Renal Protection: A Modeled Economic Evaluation
Compared with placebo, AA infusion decreases the occurrence of AKI and is cost-saving. Perioperative AA therapy is a rational approach to patient care that simultaneously protects renal function and decreases healthcare costs.
Authors
- Rosario Losiggio (ORCID: https://orcid.org/0009-0001-6181-7976)
- Alayna Carrandi (ORCID: https://orcid.org/0000-0002-5711-0417)
- Alisa M. Higgins (ORCID: https://orcid.org/0000-0001-8295-7559)
- Alessandro Pruna (ORCID: https://orcid.org/0009-0006-4588-2037)
- Domenico Pontillo (ORCID: https://orcid.org/0009-0007-1179-065X)
- Mussab Faggery
- Prof Giovanni Landoni (ORCID: https://orcid.org/0000-0002-8594-5980)
- Rinaldo Bellomo
Institutions
- Vita-Salute San Raffaele University (IT)
- Austin Hospital (AU)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
- Monash University (AU)
Publication Details
- Journal
- Journal of Cardiothoracic and Vascular Anesthesia
- Published
- 2025-08-22
- DOI
- https://doi.org/10.1053/j.jvca.2025.08.042
- Citations
- 3
- Primary Topic
- Cardiac, Anesthesia and Surgical Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 4.16
Funders
- National Health and Medical Research Council